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Abstract
Chronic wounds cause substantial morbidity and disability. Infection in chronic wounds is clinically deﬁned by routine culture methods
that can take several days to obtain a ﬁnal result, and may not fully describe the community of organisms or biome within these
wounds. Molecular diagnostic approaches offer promise for a more rapid and complete assessment. We report the development of a
suite of real-time PCR assays for rapid identiﬁcation of bacteria directly from tissue samples. The panel of assays targets 14 common,
clinically relevant, aerobic pathogens and demonstrates a high degree of sensitivity and speciﬁcity using a panel of organisms commonly
associated with chronic wound infection. Thirty-nine tissue samples from 29 chronic wounds were evaluated and the results compared
with those obtained by culture. As revealed by culture and PCR, the most common organisms were methicillin-resistant Staphylococcus
aureus (MRSA) followed by Streptococcus agalactiae (Group B streptococcus) and Pseudomonas aeruginosa. The sensitivities of the PCR
assays were 100% and 90% when quantitative and qualitative culture results were used as the reference standard, respectively. The
assays allowed the identiﬁcation of bacterial DNA from ten additional organisms that were not revealed by quantitative or qualitative
cultures. Under optimal conditions, the turnaround time for PCR results is as short as 4–6 h. Real-time PCR is a rapid and inexpensive
approach that can be easily introduced into clinical practice for detection of organisms directly from tissue samples. Characterization of
the anaerobic microﬂora by real-time PCR of chronic wounds is warranted.
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Introduction
Chronic wounds cause substantial morbidity, engender costs
over $10 billion annually in the USA [1] and especially impact
diabetics [2,3]. Chronic wounds have been ascribed to a vari-
ety of causes, most prominently poor vascular supply and
infection. Routine cultures that are used to diagnose bacte-
rial colonization and infection are time-consuming, and may
not fully reveal the microbiological communities within these
wounds because cultures often lack sensitivity in polymicro-
bial environments [4]. As such, molecular diagnostic tools
that allow reliable and consistent identiﬁcation of all patho-
gens, especially anaerobes, are highly desirable.
As an adjunct to cultures, PCR-based methods have been
evaluated for the detection of bacteria in blood [5–7], joint
ﬂuid [8] cerebrospinal ﬂuid [9], heart tissue [10] and burn
wounds [11]. Previous molecular analyses of chronic wound
microﬂora were based on the initial ampliﬁcation of bacteria
with universal primers for 16S rRNA genes followed by spe-
ciﬁc identiﬁcation approaches. These approaches included
sequencing of PCR products [12], denaturing gradient gel
electrophoresis followed by cloning and sequencing [13] and
pyrosequencing [14–16]. These identiﬁcation techniques,
however, are costly, require sophisticated instrumentation,
and therefore are not easily translatable into clinical practice.
Real-time PCR is faster than traditional PCR and does not
require post-ampliﬁcation manipulation for bacterial identiﬁca-
tion [6–8]. Application of this molecular approach to date has
been limited to the detection of speciﬁc bacterial species from
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tissue [11] or infections, such as bacterial meningitis, typically
caused by a limited number of known pathogens [9] because
there are technical challenges associated with multiplex real-
time PCR. To overcome these limitations, 16S rRNA gene
probes targeting multiple species have been designed, and
melt curve analyses have been performed to identify the
species based on characteristic melt curve proﬁles [6,17].
As an initial step toward the development of a molecular
diagnostic tool for the detection of aerobic and anaerobic
organisms, we have developed a series of real-time PCR
assays targeting 14 of the most common and clinically rele-
vant aerobic bacteria in chronic wounds. The sensitivity and
speciﬁcity of the assays was evaluated using a well-character-
ized set of chronic wound samples [16,18]. Although our
assays targeted a limited number of aerobic organisms, this
approach could be expanded to include other clinically rele-
vant organisms, including anaerobes.
Materials and Methods
Bacterial species and spiked samples
The analytical sensitivity and speciﬁcity of the PCR assays
was tested using a panel of 39 reference and clinical strains
(Table S1). The panel of bacterial species was selected
because they were either organisms targeted by the PCR
assays or organisms frequently isolated from chronic wounds
at the Johns Hopkins Wound Center (Baltimore, MD, USA)
[18]. Tissue known to be free of any of the targeted organ-
isms was used as a negative control.
To determine the limit of detection (LOD) of each assay,
serial dilutions ranging from 107–101 CFU/mL of each of the
target organisms were prepared. Each of the serial dilutions
was spiked with 20 mg of the previously described bacte-
rium-free tissue and extracted for total DNA as described
below. The LOD was calculated based on CFU/mL.
Clinical specimens
Tissue samples from chronic wounds were collected, using a
3-mm curette, from 28 patients attending the Johns Hopkins
Wound Center, as previously described [16,18]. To allow
for multiple tests to be performed, tissue samples were
divided into three portions: one was evaluated by qualitative
culture in Clinical Laboratory Improvement Amendments-
certiﬁed laboratories, the second portion was analysed by
quantitative culture and real-time PCR and the third was
used for metagenomic analysis [16]. Qualitative and quantita-
tive cultures were carried out in accordance with established
protocols [18]. The study was approved by the Johns Hop-
kins Institutional Review Board.
DNA extraction
Each sample was processed separately in a DNA-free biologi-
cal safety cabinet. Tissue homogenate (200 lL) was
extracted for total DNA with the DNeasy Blood and Tissue
DNA puriﬁcation Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions.
Primer and probe design
Three new 16S rRNA gene PCR assays were designed to
target Acinetobacter baumannii, Escherichia coli, Klebsiella oxytoc-
a, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis/
vulgaris and Pseudomonas aeruginosa (Table 1). The Enterococ-
cus/Streptococcus assay and Staphylococcus aureus assays have
been described previously [6,19]. A previously validated meth-
icillin-resistant S. aureus (MRSA) PCR assay that can differenti-
ate between MRSA and methicillin-resistant coagulase-
negative staphylococci (CoNS) was used with minor modiﬁca-
tions [20]. For detection of Group B streptococci (GBS), the
previously described forward primer TTTCACCAGCTGT
ATTAGAAGTA [21] was used in combination with the newly
designed reverse primer GTTCCCTGAACATTATCTTT
GAT. All primers and probes were synthesized by TIB Molbiol
(Adelphia, NJ, USA).
Real-time PCR assays
All assays were carried out in two runs: one run included
all probe-based assays (Table 1) and the other included the
SYBR Green-based assays (GBS and MRSA). PCR reactions
were carried out individually, but in parallel, in 96-well plates
in 20-lL reactions consisting of 10 lL of 2· LightCycler 480
Probes Master/SYBR Green Master, 1 lM of each primer
and probe (if necessary), 5 lL of extracted DNA and PCR-
grade water to a ﬁnal volulme of 20 lL. Every run included
positive and negative controls. The ampliﬁcation parameters
included steps at 95C for 10 min, followed by 35 cycles at
95C for 10 s, 55C for 10 s and 72C for 10 s, followed
by probe melting, which consisted of a continuous ﬂuores-
cence reading from 50–85C at ﬁve acquisitions per 1C/s.
PCR reactions were carried out in duplicates on the Light-
Cycler 480 System (Roche Applied Science, Indianapolis, IN,
USA).
Post-PCR analysis
Samples were considered to be positive for the targeted
species if they yielded an ampliﬁcation curve three cycles
below the negative control, and had a characteristic melt
curve proﬁle similar to that of the positive control. Given
the controversy regarding the adequacy of qualitative culture
assessment [18], we evaluated the overall sensitivity and
speciﬁcity of the PCR assays compared to qualitative and
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quantitative culture results as reference standards. The total
possible number of PCR-identiﬁable organisms (n = 546) was
used to calculate the speciﬁcity of the PCR assays and was
based on the notion that the PCR assays can detect up to
14 different species in each of the 39 samples. A 95% CI
based on binomial distribution was used to provide infer-
ences for clinical sensitivity and speciﬁcity.
Results
Analytical sensitivity and speciﬁcity of the PCR assays using
spiked samples
Each of the assays correctly and exclusively identiﬁed their
respective target organisms. The LOD of each assay was in
the range 101–102 CFU/mL. Species were differentiated by
their unique melt curve proﬁle (Fig. 1a) resulting from DNA
sequence variations in the binding region of the FL probe
(Table 1). Although Klebsiella and Proteus can be easily differ-
entiated, speciﬁc species of these genera with identical DNA
sequences (Table 1) could not be differentiated by their melt
curve proﬁle (Fig. 1a). A secondary PCR assay, which can
simultaneously detect Serratia marcescens was designed to dif-
ferentiate K. pneumoniae from K. oxytoca (Fig. 2). A PCR
assay to differentiate P. mirabilis from P. vulgaris was not avail-
able for this study. To evaluate the theoretical sensitivity and
speciﬁcity of using a single probe for the identiﬁcation of
multiple species, we analysed a spiked sample containing
E. coli, K. oxytoca, M. morganii and P. mirabilis with the PCR
assay targeting these four species. As shown in Fig. 1b, this
PCR assay can simultaneously identify up to three related
species with a single set of hybridization probes.
Clinical samples and culture-based results
Thirty-nine samples were collected, in 39 wound visits, from
28 subjects (16 males and 12 females, age range 33–
83 years); 15 (54%) patients were diabetic. Primary ulcer
diagnoses were neuropathic (39%), decubitus and/or pres-
sure (21%), venous (15%), traumatic and/or surgical (11%)
and other (14%). Ninety-seven percent (38/39) of wound
samples were positive for at least one organism by culture,
and 60% of samples had three or more organisms. The most
prevalent organisms identiﬁed by culture were MRSA (42%)
followed by P. aeruginosa (28%) and Group B streptococcus
(21%). Methicillin-sensitive S. aureus was present in 17% of
the wounds. Anaerobes (Prevotella, Bacteroides and Peptostrep-
tococcus) accounted for 11% (10/92) of the organisms cul-
tured and were recovered from 21% (8/39) of the wound
samples (Table 2). Of the 73 organisms isolated by quantita-
tive cultures (Table 2), quantitative data (CFU/g) were avail-
able for 70 of the organisms, and 90% (63/70) of these
organisms were present at ‡105 CFU/g of tissue.
TABLE 1. Primers and probes used in the present study
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Diagnostic sensitivity and speciﬁcity of the PCR assays with
clinical samples
Eighty-two percent (31/38) of the culture-positive wound
samples had organisms that were identiﬁable by the PCR
assays. The remaining seven samples were colonized by
CoNS and/or Corynebacterium (6), and Group G streptococci
(1). Overall, the PCR assays targeted 73% (60/82) and 75%
(55/73) of the aerobic organisms isolated by qualitative and
quantitative cultures, respectively. The majority of the aero-
bic organisms not targeted by the PCR assays were CoNS
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and Corynebacterium (Table 2). The PCR assays correctly
identiﬁed 54 of the 60 aerobic organisms isolated by qualita-
tive cultures, and 55 of the 55 organisms recovered by quan-
titative cultures (Table 3A). The PCR assays correctly
identiﬁed 100% (48/48) and 92% (61/66) of the aerobic
organisms isolated by the two culture methods, and by
either of the two culture methods, respectively (Table 2).
The calculated overall sensitivity and speciﬁcity of the PCR
assays in comparison to the quantitative culture results as
the reference standard were 100% (55/55) (95% CI 93.5–
100%) and 96.7% (475/491) (95% CI 94.8–98.1%), respec-
tively. The PCR assays were 90.0% (54/60) sensitive (95% CI
79.5–96.2%) and 96.5% (469/486) (95% CI 94.5–98.0%) spe-
ciﬁc in comparison to qualitative culture results.
Discordant species-speciﬁc PCR and culture results
Six organisms from six samples yielded discordant qualitative
culture and PCR results (Table 3B2). E. coli (WS34), Group
A streptococcus (WS40), K. pneumoniae (WS12) and P. mira-
bilis (WS27) were all reported as showing minimal growth
during qualitative analysis, but were negative by quantitative
cultures and PCR.
Two isolates [K. pneumoniae (WS17) and P. mirabilis
(WS38)] were reported as showing heavy growth by
qualitative culture but were PCR- and quantitative culture-
negative.
The PCR assays identiﬁed DNA from ten organisms that
were not reported by qualitative or quantitative cultures
(Table 3B1). Additionally, there were seven samples with
qualitative culture-negative, quantitative culture-positive and
PCR-positive results (Table 3B2), and six samples with quali-
tative culture-positive, quantitative culture-negative and PCR-
positive results (Table 3B3).
Antimicrobial therapy and microbial wound content
To determine whether antimicrobial therapy impacted assay
performance, we compared the culture and PCR results for
subjects recently treated with antibiotics and those untreated.
An average of 3 and 2.1 isolates were recovered by culture
from untreated and treated wounds, respectively. There was
no difference in the number of isolates (2.2) recovered by
culture from treated wounds regardless of whether the last
dose of antibiotic was taken 24 h or 2 weeks prior to sample
collection. However, 46% (6/13) of the wounds that were
treated within 24 h of sample collection were either colonized
with CoNS or Corynebacterium (5) or were culture-negative
(1). Eighty percent (8/10) of the organisms exclusively
detected by PCR were from untreated wounds (Table 3B1).
TABLE 2. Numbers of isolates/
microorganisms detected by quali-
tative and quantitative culture and
by PCR
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Discussion
Real-time PCR assays that can simultaneously target multiple
species may be a useful adjunct for the rapid and accurate
identiﬁcation of bacterial pathogens in chronic wounds. The
only commercially available, multi-species PCR-based test,
SeptiFast [22–24], has not been applied to chronic wounds
and is not available in the USA. Using our own panel of PCR
assays and chronic wound samples, we demonstrated the
utility of using a targeted multi-species, real-time PCR
approach for the rapid detection of bacterial species directly
from tissue.
As a proof of principle, we designed a panel of PCR
assays to target the most clinically relevant aerobic bacte-
rial species commonly isolated from chronic wounds based
on culture results from our patient population and previ-
ous studies. S. marcescens, which is not frequently isolated
from chronic wounds, was not purposely targeted, but
could be detected by one of the assays. Although CoNS
and Corynebacterium are frequently isolated from chronic
wounds, PCR assays targeting these organisms were not
included in the panel because they are not believed to be
clinically signiﬁcant in the setting of chronic wounds. PCR
assays targeting Alcaligenes spp., Citrobacter freundii, Enterob-
acter cloacae, Group G streptococci, Providencia stuartii and
Viridans group streptococci were not included in the panel
of assays because, as demonstrated in the current study,
they are not commonly isolated from the chronic wounds
of our patients (Table 2). However, some of these organ-
isms are clinically relevant and should be targeted in future
studies.
The sensitivity of our PCR assays was excellent compared
to that of cultures. The assay system is versatile because it
can be run individually or as a panel; additional assays target-
ing other clinically relevant bacterial species, including anaer-
obes can easily be added to a panel, and can be adapted to
other biological materials such as blood. Under optimal con-
ditions, the turnaround time for PCR results can be as short
as 4–6 h.
A total of six qualitative culture-positive, PCR-negative
samples were noted. There are two possible explanations
for these results. (i) Positive cultures resulting from labora-
tory contamination. None of the isolates were revealed by
TABLE 3. Concordance and discordance of qualitative and quantitative culture results in comparison to species-speciﬁc PCR
results
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quantitative cultures and most of them showed minimal
growth during qualitative analysis. (ii) A lack of sufﬁcient
DNA for ampliﬁcation or excess background DNA. It has
been suggested that PCR fails to reach its theoretical sensi-
tivity because of the use of a small sample volume after a
series of enzymatic inductions of cell lysis, which may or may
not effectively isolate the microbial DNA [25].
The PCR assays identiﬁed DNA from ten organisms that
were not revealed by either qualitative or quantitative cul-
tures. Recent antibiotic treatment of the patients is unlikely
to be the reason for the discordant results because the
majority of them had not received topical or systemic ther-
apy within the 2 weeks prior to sample collection. There are
several possible explanations for the culture-negative, PCR-
positive results, including: (i) a lack of sensitivity of cultures
in polymicrobial settings, which has been previously reported
in the setting of chronic wounds [4]; (ii) molecular detection
of nonviable bacteria; (iii) false-positives resulting from cross-
reactivity with other species that were not cultured and that
were not part of the panel used to determine the speciﬁcity
of the PCR assays.
To further expand the applicability of this targeted
approach, we have conducted preliminary studies with previ-
ously reported real-time PCR assays targeting the Bacteroides
spp. and Prevotella spp. [26,27] but have found them to lack
speciﬁcity in the setting of chronic wounds. Given that
anaerobes such as Bacteroides and Prevotella comprised a
large portion of the chronic wound microﬂora communities
[14–16] and that these species cannot be easily isolated by
culture, real-time PCR assays targeting these anaerobes as
well as Peptostreptococcus spp. should be designed and rou-
tinely used in the characterization of the microﬂora of
chronic wounds. We are currently working on developing
assays targeting several anaerobic species.
In conclusion, we demonstrated that a targeted real-time
PCR approach can be used for the rapid detection of the
most prevalent cultivable, aerobic organisms isolated from
chronic wounds. Additionally, this approach is fast and uses
instrumentation that is becoming more readily available in
the clinical setting. Subsequent to the development of addi-
tional assays targeting other clinically relevant aerobic and
anaerobic organisms, we look forward to developing a
rapid, cost-effective, clinically applicable molecular diagnostic
panel to serve in the diagnosis and care of chronic wounds.
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